ADXN

Addex Therapeutics
ADXN

Overview Fund Activity

10 hedge funds and large institutions have $1.21M invested in Addex Therapeutics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+5
Holders Change %
+100%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NMC
NEA Management Company
Maryland
$830K
2
AC
Armistice Capital
New York
$256K
3
Renaissance Technologies
Renaissance Technologies
New York
$24K
4
FIA
FNY Investment Advisers
New York
$17K
5
Millennium Management
Millennium Management
New York
$16K

Top Sellers

1
OMC
Old Mission Capital
Illinois
$0
2
UBS Group
UBS Group
Switzerland
$6K
Name Holding Trade Value Shares
Change 		Shares
Change %
NMC
1
NEA Management Company
Maryland
$830K +$692K +235,363 +500%
AC
2
Armistice Capital
New York
$256K +$53.6K +3,349 +26%
NLVP
3
New Leaf Venture Partners
New York
$40K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$24K +$24K +1,477 New
FIA
5
FNY Investment Advisers
New York
$17K +$17K +1,125 New
Millennium Management
6
Millennium Management
New York
$16K +$16K +998 New
TSS
7
Two Sigma Securities
New York
$10K +$10K +604 New
Citadel Advisors
8
Citadel Advisors
Florida
$10K +$10K +640 New
UBS Group
9
UBS Group
Switzerland
$6K -$784 -46 -12%
OMC
10
Old Mission Capital
Illinois
– -$36K -1,557 Closed